Abiopharma

(70% Positive) Caribou Biosciences, Inc. (CRBU) Announces Enrollment Update for reported Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

(80% Positive) Akouos, Inc. (AKUS) Announces Business Combination

(80% Positive) Mereo BioPharma (MREO) Announces Clinical Development Update (Form 6-K)

(99% Neutral) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K)

9 Meters Biopharma to Present at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

(75% Positive) KALVISTA PHARMACEUTICALS, INC. (KALV) Provides Update on Retire for Planned Transition - Cambridge

(10% Negative) MACROGENICS, INC. (MGNX) Announces Delay in treatment Trials for certain blood cancers Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Efficacy Assessment

(99% Neutral) RUBIUS THERAPEUTICS, INC. (RUBY) Announces Executive Departure

(99% Neutral) Legend Biotech (LEGN) Files Form 6-K